Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-02-03
1986-12-09
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530330, A61K 3702, C07K 706
Patent
active
046280456
ABSTRACT:
A peptide having the amino acid sequence Asp-Ser-Glu-Pro-Arg and capable of blocking immune complex binding to immunoglobulin Fc receptors is disclosed.
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4392997 (1983-07-01), Goldberg
Hunsicker, J. Exp. Med. 150 413 (1979).
Hunninghake, et al., Clin. Immunol. Rev. 1 (3) 337 (1981-1982).
Johnson et al., (J. Immunol., 117, 1491 (1975).
Boackle, et al., Nature 282, 742 (1979).
Prystowksy, et al., (Biochemistry, 20, 6349 (1981)).
Lukas, et al., (J. Immunol. 127, 2555 (1981)).
Burton et al., Nature 288, 338 (1980).
Veretennikova, et al., Int. J. Peptide Protein Res., 17, 430 (1981).
Morgan et al., Proc. Nat'l Acad. Sci. USA 79, 5388 (1982).
Ciccimarra, et al., Proc. Nat'l Acad. Sci. USA 72, 208 (1975).
Stanworth, Mol. Immunol. 19 1245 (1982).
Hamburger, Science 189, 389 (1975).
Plummer et al., Fed. Proc. 42 713 (1983).
Hamburger, Immunology 38, 78 (1979).
Biochem. J., 180 665, 181 623 (1979).
Barnett-Foster et al., Mol. Immunol. 19 407 (1982).
Barnett-Foster et al., J. Immunol. 120, 407 (1978).
Takatsu et al., J. Immunol. 114 1838 (1975).
Dorrington et al., Immunol Rev. 41, 3 (1978).
Perey-Montfort, Mol. Immunol. 19 1113 (1982).
Kuehl et al., Science 210 978 (1980).
Goodwin, Clin. Immunol. Immunopath 15 106 (1980).
Stenson et al., Immunol. 125 1 (1980).
Leung et al., J. Immunol. 129 1742 (1982).
Fischer et al., J. Immunol. 126 1452 (1981).
Klein et al., Immunol. 48 337 (1983).
Goodwin, et al., Cancer Immunol. Immunother., 8, 3 (1980).
Samuelsson, Science 220 568 (1983).
Weiss et al., J. Immunol. 129 309 (1982).
Fantone, J. Pathol. 107 397 (1982).
Perex, et al., Textbook Rheumatogoly, vol. 1, W. B. Saunders Philadelphia, (1981), 179-194.
Dreisin et al., N. Engl. J. Med. 298 358 (1978).
Lawrence et al., N. Engl. J. Med. 302 1187 (1980).
Holdsworth, J. Immunol. 130 735 (1983).
Striker, J. Exp. Med. 149, 127 (1979).
Kumar in Pathologic Basis of Disease eds. S. L. Robbins & P. S. Cotran, W. B. Saunders; Philadelphia, 1979, p. 304.
Melwicz, et al., Clin. Exp. Immunol., 49, 364 (1982).
Spiegelberg, et al., 42, 124 (1983).
Scott, et al., Fed. Proc. 42, 129 (1983).
McMillan, N. Engl. J. Med., 304, 1135 (1981).
Fehr, et al., (N. Engl. J. Med., 306, 1254 (1982)).
Imbach et al., (Lancet, Jun. 2, (1981)), p. 1228.
Oberbarnscheidtex, et al., Immunol., 35, 151 (1978).
Kolsch et al., Immunol., Rev., 49, 61 (1980).
Fridman et al., Immunol. Rev. 56, 51 (1981).
Bich-Thuy, J. Immunol., 129, 150 (1982).
Smolen et al., J. Immunol. 129 10150 (1982).
Goeken et al., Hum. Immunol., 6, 79 (1983).
Kabelitz et al., Eur. J. Immunol., 12, 687 (1982).
Sakane et al., Proc. Nat'l Acad. Sci. USA 75, 3464 (1978).
Miyasaka et al., J. Clin. Invest., 66 928 (1980).
James et al., J. Clin. Invest. 66, 1305 (1980).
Hodgkin's Lymphoma (Engleman, et al., J. Clin. Invest., 66 149 (1980)).
Smith et al., J. Nat'l Cancer Inst. 58, 579 (1977).
Cochrane et al., Lancet 1, 441 (1976).
Douvas, Ann. Immunol. Inst. Pasteur, 132c, 307 (1981).
Ulcerative Colitis (Hibi, et al., Clin. Exp. Immunol., 49, 75 (1982).
Hashimoto's Thyroiditis (Calder et al., Clin. Exp. Immunol., 14, 153 (1973)).
Gonzalez-Molina et al., J. Clin. Inves., 55, 616 (1977).
Merrifield, J. Am. Chem. Soc., 85, 2149-2154 (1963).
Barany & Merrifield in the Peptides, eds. E. Gross & F. Meinehofer, vol. 2, (Acad. Press (1980)) 2285.
Synthesis of a Tetrapeptide by R. B. Merrifield, J. of Amer. Chem. Soc. 85, 22154 (1963).
The Journal of Exp. Med. vol. 150, (1979).
Clin. Immunol. Rev. 1(3) 337-374 (1981-1982).
Immunetech Pharmaceuticals
Phillips Delbert R.
LandOfFree
Immunotherapeutic antiallergic polypeptide agents which bind to does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic antiallergic polypeptide agents which bind to , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic antiallergic polypeptide agents which bind to will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385492